Quick summary: Semaglutide (Wegovy) and tirzepatide (Zepbound) are both once-weekly injectable GLP-1 medications that reduce appetite and produce meaningful weight loss. Tirzepatide activates an additional hormone pathway and tends to produce greater average weight loss in clinical trials. Both carry similar GI side effects and the same thyroid and pancreatitis warnings. The right choice depends on your medical history, insurance coverage, and treatment goals — determined at a clinical evaluation, not from a comparison chart.
Medically reviewed by the clinical team at OC Weight Loss & Med Spa. Last updated: June 12, 2026.
If you’re weighing semaglutide and tirzepatide for weight loss, you’re not alone. These two medications dominate the GLP-1 conversation right now, and for good reason: both have produced weight-loss results that were unthinkable a decade ago. But they aren’t interchangeable.
Tirzepatide tends to push the scale further. Semaglutide has more years of real-world use behind it. The “right” choice depends on your goals, your tolerance for side effects, what your insurance covers, and what your clinician thinks fits your medical history.
Below is a side-by-side look at how each works, what the trials show, what they cost, and how to decide with a provider who knows your full picture.
What Are Semaglutide And Tirzepatide?
Semaglutide is a GLP-1 receptor agonist — it mimics a single gut hormone (glucagon-like peptide-1) the body releases after eating. That hormone helps regulate appetite, slows gastric emptying, and improves blood-sugar control. Semaglutide is sold under the brand names Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management.
Tirzepatide is a dual agonist — it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. Hitting two appetite- and metabolism-related pathways at once is what sets it apart from single-target GLP-1s. Tirzepatide is marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management.
Both are once-weekly subcutaneous injections delivered by pen. Both require a clinician’s prescription and a structured titration schedule. The differences start to matter when you compare what happens inside the body.
How Do They Work Differently?
How Semaglutide Works
Semaglutide binds to GLP-1 receptors throughout the body — in the brain, the gut, and the pancreas. The result: you feel full sooner, hunger between meals quiets down, and your pancreas releases insulin more efficiently when blood sugar rises. Most people start at a low dose (0.25 mg weekly) and titrate up over several months to reduce GI side effects.
Anyone considering semaglutide for weight loss should plan on regular check-ins, lab work, and a structured nutrition plan. The medication works best as part of a program, not as a stand-alone fix.
How Tirzepatide Works
Tirzepatide activates GLP-1 receptors the same way semaglutide does, but it also activates GIP receptors. GIP plays a role in fat metabolism and the body’s insulin response after eating. Stimulating both pathways appears to amplify appetite suppression and may improve how the body handles incoming calories. The dual mechanism is the leading explanation for why tirzepatide tends to outperform semaglutide on weight loss in head-to-head data.
Like semaglutide, tirzepatide starts low (2.5 mg weekly) and titrates up every four weeks until you reach a maintenance dose your body tolerates well.
How Much Weight Can You Lose On Each?
This is usually the first question people ask, and the trial data give the cleanest answer.
In the STEP 1 trial of semaglutide 2.4 mg, adults with obesity (without type 2 diabetes) lost an average of 14.9% of body weight at 68 weeks when paired with lifestyle intervention, versus 2.4% on placebo.
In the SURMOUNT-1 trial of tirzepatide, adults with obesity (without type 2 diabetes) lost an average of 15.0%, 19.5%, and 20.9% of body weight at the 5 mg, 10 mg, and 15 mg doses, respectively, at 72 weeks.
Translation: at the highest tirzepatide dose, average weight loss is roughly 6 percentage points higher than peak semaglutide. For a 220-pound starting weight, that’s about 13 extra pounds on average. Individual responses vary widely — some people lose more, some lose less, on either drug.
One thing the trials make clear: results in both arms were achieved alongside structured lifestyle support — calorie guidance, behavioral counseling, and regular follow-up. The medication is not the whole plan.
Side Effects And Tolerability
The side-effect profiles are similar because both drugs slow gastric emptying:
- Nausea (most common, especially during dose escalation)
- Constipation or diarrhea
- Reflux, burping, or a sulfur taste
- Fatigue, especially in the first few weeks
- Rare but serious: pancreatitis, gallbladder issues, and a labeled warning about thyroid C-cell tumors based on rodent studies
Most GI side effects fade as the body adjusts. Slow titration helps, as do a few practical habits: smaller meals, more protein and fiber, fewer fried or very rich foods, and adequate water. People with a personal or family history of medullary thyroid carcinoma, MEN 2, prior pancreatitis, or severe gastroparesis should not take either medication.
Cost, Insurance, And Availability
Out-of-pocket pricing for both medications typically runs $1,000–$1,400 per month at retail pharmacies. Insurance coverage varies widely — many commercial plans cover the diabetes versions (Ozempic, Mounjaro) but require prior authorization or deny the weight-loss versions (Wegovy, Zepbound).
California Medi-Cal beneficiaries should also be aware that, beginning January 1, 2026, GLP-1 drugs prescribed for “weight loss only” are no longer covered. If you’re navigating coverage, your clinic should help you check eligibility, prior authorization, and manufacturer savings cards before you start.
Compounded versions of semaglutide and tirzepatide are sold by some clinics. The FDA’s stance on compounded GLP-1 drugs has shifted as brand-name supply has stabilized, and quality varies. Ask any provider you’re considering exactly where their medication comes from and what oversight applies.
Which One Is Right For You?
There isn’t a one-size answer. A reasonable framework:
- Semaglutide may fit better if you want a longer real-world track record, your insurance covers Wegovy or Ozempic but not Zepbound, or you’ve responded well to GLP-1 therapy before.
- Tirzepatide may fit better if you want maximum weight-loss potential, you’ve plateaued on semaglutide, or you have type 2 diabetes and your provider thinks the dual-pathway mechanism could help your A1C alongside your weight.
- Neither is appropriate if you have a history of medullary thyroid carcinoma or MEN 2, prior pancreatitis, severe gastroparesis, or you’re pregnant or trying to conceive.
Both medications work best when paired with the basics: protein-forward eating, strength training to protect lean muscle, sleep, and regular medical follow-up. Neither one substitutes for those.
What To Look For In A Provider
The medication is one piece of the program. The team around it matters as much:
- A real intake — full medical history, medications, labs, and a conversation about your goals
- A clear titration plan and a phone number you can reach when side effects show up
- Nutrition guidance you can actually follow
- Strength-training recommendations to protect muscle mass during weight loss
- Transparent pricing — including what the medication costs out of pocket if your insurance doesn’t cover it
Anything less and you’re paying for a prescription, not a program.
Frequently Asked Questions
Can I switch from semaglutide to tirzepatide?
Yes. Switching is common when a patient has plateaued on semaglutide or wants to try the dual-pathway mechanism. Your provider will guide the transition, typically starting tirzepatide at its lowest dose regardless of where you were on semaglutide.
How long do I need to stay on these medications?
Both medications are intended for chronic weight management. Clinical data show that weight typically returns when the medication is stopped without sustained lifestyle changes in place. Duration is a decision made with your provider based on your health goals and response.
Is compounded semaglutide or tirzepatide safe?
Compounded versions are not FDA-approved and quality varies by pharmacy. As brand-name supply stabilizes, the FDA has been restricting compounded GLP-1 availability. Ask any clinic you’re considering to identify their pharmacy, its accreditation, and what testing the product undergoes.
Do these medications affect fertility or pregnancy?
Both semaglutide and tirzepatide should be discontinued before attempting conception. They are not approved for use during pregnancy, and some evidence suggests they may increase fertility as weight improves — making contraception planning an important part of the pre-treatment conversation.
What happens at the first appointment?
A full intake includes your medical history, current medications, relevant labs, weight history, and a conversation about your goals. From there, your provider recommends a starting medication and dose, explains the titration schedule, and sets expectations for follow-up. No prescription is issued without this evaluation.
Get A Personalized Recommendation
If you’ve been considering GLP-1 therapy and you’re not sure which medication is the right starting point, the most efficient next step is a clinical evaluation that weighs your medical history, your goals, your insurance coverage, and your day-to-day habits. At OC Weight Loss & Med Spa in Mission Viejo, CA, we build a plan around the medication and the lifestyle support that fits you — not a one-size protocol.
Book a free consultation
Book a Free Consultation